Slow to adopt stroke treatment TPA in emergency care
AP reports surveys at the AHA conference show many doctors remain hesitant to use tissue plasminogen activator as the first stroke treatment due to bleeding risk. Since FDA approval in 1996, TPA can cut paralysis risk by 30 to 40 percent when given within three hours, but neurologists and ER doctors worry about safety without rapid neurologist input and CT confirmation.
MENTIONED IN THIS ARTICLE
Orlando
Fla
American Heart Association
U.S. Food and Drug Administration
Thomas Brott
University of Cincinnati Medical Center
Brott
Lewis Morgenstern
University of Texas In Houston
Texas Neurologists
TPA
Paul Laland
Genentech
U.S
Also Mentioned on This Page
United States
Brett
Patricia Davis
University of Iowa
Iowa
Morgan Modular
D. Brooks
Frinco
S. Stockton
Monahans
Coes
Andrews Hwy
Odessa
Sun
ADEE
Bete Ey
Eae Ees
Bese TN
Hollywood
Estée Lauder
Dillard's
Mastercard
American Express
Discover
Diners Club
Music City Mall
Estee Lauder
Touet Nermal